Go to the list of all blogs
AI dvisor's Avatar
published in Blogs
Nov 06, 2026
TickeronGET DAILY SIGNALS
Why Is Sportradar Group AG (SRAD) Stock Down -4.66% Today?

Why Is Sportradar Group AG (SRAD) Stock Down -4.66% Today?

Key Takeaways

  • SRAD shares fell roughly 4.66% to about $13.51, down $0.66 from the prior session's close of $14.17.
  • The decline extends a fade from the stock's post-earnings rally earlier in the week, as investors weighed fresh analyst caution and price-target reductions.
  • A persistent regulatory and litigation overhang tied to earlier short-seller allegations continues to weigh on sentiment.
  • Broader trading in sports-data and gaming-technology names has been choppy, adding to the pressure on SRAD.
  • Traders are watching upcoming court and regulatory developments, along with further analyst revisions and earnings follow-through.
  • For more detail on the stock's valuation, results, and outlook, explore the dedicated Price Targets, Earnings, and Forecast pages.
  • To see which AI-powered strategies are performing best right now, visit the Trending AI Robots section.

Opening Summary

Sportradar Group AG (SRAD) is a Switzerland-based sports technology company that supplies official sports data, odds feeds, betting, iGaming, media, and prediction-market solutions to operators and leagues worldwide, including the NBA, MLB, NHL, FIFA, and UEFA. In Thursday's session, the stock moved sharply lower, trading down approximately 4.66% to around $13.51, compared with the previous session's closing price of $14.17. The decline reflects a combination of analyst caution, an ongoing legal and regulatory overhang, and profit-taking after the stock's brief post-earnings surge earlier in the week.

Analyst Downgrades and Price-Target Cuts

A cluster of cautious notes from Wall Street has been a central driver of the selling pressure. Following the company's third-quarter results, JPMorgan maintained a Neutral rating while trimming its price target, and Truist Securities adopted a more cautious tone, citing softer industry trends in the broader sports-betting and gaming-data landscape. Other firms also lowered price targets, reflecting concerns about growth durability and execution even as the company continues to report double-digit revenue expansion. Multiple analyst actions in a short window can amplify downward momentum, particularly for a stock already trading near the lower end of its 52-week range.

Lingering Short-Seller and Litigation Overhang

The market reaction also reflects the continued shadow of activist short-seller reports from earlier in 2026. Reports published by Muddy Waters Research and Callisto Research alleged that SRAD had exposure to operators in black- and grey-market gambling jurisdictions, contradicting the company's public statements about strict compliance. The company has repeatedly denied the allegations, stating that it works exclusively with licensed operators and follows rigorous compliance standards. Nevertheless, the claims triggered a sharp selloff at the time and a wave of securities class-action lawsuits, keeping regulatory and reputational risk firmly in the conversation for investors. This unresolved backdrop has made the shares vulnerable to renewed bouts of selling.

Post-Earnings Profit-Taking

The decline also follows a notable earnings-driven move earlier in the week. Sportradar reported third-quarter revenue of roughly €362.5 million, which topped consensus estimates, though adjusted earnings per share of about €0.09 came in slightly below expectations. The revenue beat and management's upbeat commentary on prediction markets and the IMG ARENA integration initially propelled the shares higher, but that rally has since reversed. When a stock rises quickly on earnings and then retreats, the pullback often reflects traders locking in gains as the initial enthusiasm cools and broader concerns reassert themselves.

Market Context and Trading Activity

Trading volume around SRAD has been elevated relative to its quieter periods, consistent with a stock reacting to earnings and a steady stream of analyst and legal headlines. The move has unfolded against a mixed backdrop for sports-data and gaming-technology peers, with sector sentiment uneven as investors weigh growth opportunities in prediction markets against regulatory uncertainty. Technically, the shares have remained under pressure after a steep decline from their all-time high reached in mid-2025, and they continue to trade well below their longer-term moving averages, leaving the stock vulnerable to further volatility without a decisive positive catalyst.

What Comes Next for SRAD

Looking ahead, investors will be focused on several factors. The progress of the pending securities class-action litigation and any regulatory reviews will be closely monitored, as will any additional disclosures from management regarding its compliance practices. Analyst expectations around revenue growth, adjusted EBITDA margins, and the contribution from prediction-market partnerships and the IMG ARENA integration will also shape sentiment ahead of the next earnings release. Risks include further analyst downgrades, adverse legal or regulatory developments, and sustained pressure on sports-betting data valuations. On the other side, continued momentum in prediction markets and official data demand could provide a stabilizing influence if execution remains strong.

Trending AI Robots

Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are showcased in the curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving investors a way to explore data-driven approaches tailored to different market environments. Explore the Trending AI Robots page to see which strategies are currently leading the pack.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SRAD

SRAD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SRAD turned positive on October 22, 2026. Looking at past instances where SRAD's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on SRAD as a result. In 72 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

SRAD moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRAD crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

Following a +12.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRAD advanced for three days, in 224 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The 10-day RSI Indicator for SRAD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 24 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRAD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

SRAD broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SRAD entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. SRAD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.358) is normal, around the industry mean (-2.526). SRAD has a moderately high P/E Ratio (236.167) as compared to the industry average of (15.160). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (2.627) is also within normal values, averaging (70.854).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRAD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.4B. The market cap for tickers in the group ranges from 39 to 281.08B. SAP holds the highest valuation in this group at 281.08B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -2%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -5%. IFBD experienced the highest price growth at 119%, while MNTN experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 88%. For the same stocks of the Industry, the average monthly volume growth was 117% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 58
Price Growth Rating: 58
SMR Rating: 77
Profit Risk Rating: 93
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Industry
N/A
Address
Feldlistrasse 2
Phone
+41 715177200
Employees
4882
Web
https://www.sportradar.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Revolution Medicines (RVMD) stock surged +41% over the past 30 days, primarily driven by positive topline results from a pancreatic cancer trial announced mid-period. The stock experienced high volatility with a sharp spike followed by consolidation, reflecting investor enthusiasm for clinical progress.
PANW stock rose approximately +11% over the past 30 days, driven by recovery in cybersecurity sentiment and strong enterprise wins. Over the past quarter, shares gained +3% amid volatility, reflecting a post-earnings dip followed by steady rebound.
Why Is Sportradar Group AG (SRAD) Stock Down -4.66% Today?